D. Bareford

Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia

Claire Harrison, Peter J. Campbell, Georgina Buck et al. · New England Journal of Medicine · 2005 · 921 citations · Full text

Medicine, Hematology, Pharmacotherapy +3

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

Peter J. Campbell, Linda M. Scott, Georgina Buck et al. · The Lancet · 2005 · 645 citations

Medicine, Genetics, Hematology +13

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip Beer, Peter J. Campbell, Linda M. Scott et al. · Blood · 2008 · 423 citations · Full text

Life Sciences, Genetics, Hematology +13

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

Mary Frances McMullin, D. Bareford, Peter J. Campbell et al. · British Journal of Haematology · 2005 · 336 citations

Medicine, Hematology, Internal Medicine +11

Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm

Philip Beer, François Delhommeau, Jean-Pierre Lecouedic et al. · Blood · 2009 · 300 citations · Full text

Medicine, Hematology, Oncology +10